{"id":"NCT00023452","sponsor":"Centers for Disease Control and Prevention","briefTitle":"Three Months of Weekly Rifapentine and Isoniazid for M. Tuberculosis Infection","officialTitle":"TBTC Study 26: Effectiveness and Tolerability of Weekly Rifapentine/Isoniazid for 3 Months Versus Daily Isoniazid for 9 Months for the Treatment of Latent Tuberculosis Infection","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2001-06","primaryCompletion":"2010-10","completion":"2013-09","firstPosted":"2001-09-10","resultsPosted":"2012-09-27","lastUpdate":"2024-08-27"},"enrollment":8053,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"PREVENTION"},"conditions":["Tuberculosis"],"interventions":[{"type":"DRUG","name":"RPT + INH once weekly for 3 months given by DOT","otherNames":["INH","isoniazid","I","Rifapentine","RPT","P","Priftin","3HP","3INH/RPT"]},{"type":"DRUG","name":"Isoniazid (INH) daily for 9 months","otherNames":["Isoniazid","INH","I","9INH"]}],"arms":[{"label":"Daily Isoniazid","type":"ACTIVE_COMPARATOR"},{"label":"Weekly Isoniazid / Rifapentine","type":"EXPERIMENTAL"}],"summary":"Open-label, multi-center, Phase III clinical trial to compare the effectiveness and tolerability of a three-month (12-dose) regimen of weekly rifapentine and isoniazid (3RPT/INH) to the effectiveness of a nine-month (270-dose)regimen of daily isoniazid (9INH) to prevent tuberculosis (TB) among high-risk tuberculin skin-test reactors, including children and HIV-infected persons, who require treatment of latent TB infection (LTBI).","primaryOutcome":{"measure":"Cumulative Rate of Culture-Confirmed TB Disease in Participants â‰¥18 Years of Age AND Culture-Confirmed or Probable (Clinical) TB Disease in Participants Less Than [<]18 Years of Age at 33 Months After Enrollment","timeFrame":"Baseline up to Month 33","effectByArm":[{"arm":"9INH","deltaMin":0.43,"sd":null},{"arm":"3RPT/INH","deltaMin":0.19,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":null}]},"eligibility":{"minAge":"2 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":10},"locations":{"siteCount":26,"countries":["United States","Brazil","Canada","Spain"]},"refs":{"pmids":["22150035","38640958","31690107","29393655","28087928","27243774","26951571","25904367","25580725"],"seeAlso":["https://www.cdc.gov/tb/research/tbtc.html?CDC_AAref_Val=https://www.cdc.gov/tb/topic/research/tbtc/default.htm"]},"adverseEventsSummary":{"seriousAny":{"events":102,"n":3759},"commonTop":["Hypersensitivity","Hepatitis","Pregnancy","Medication error"]}}